Drug recall D-0551-2023
Product
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Reason for recall
CGMP Deviations
Lots and codes
a) Lot #: F106252201, Exp. Date 09/30/2024; F106252301, F106252303, Exp. Date 5/31/2025; F106252304, Exp. Date 07/31/2025 b) Lot #: F106252302, Exp. Date 07/31/2025
Recall details
- Recalling firm
- Northwind Pharmaceuticals LLC, Indianapolis, IN
- Quantity
- a) 230 bottles; b) 22 bottles
- Distribution
- Nationwide with the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 16, 2023
Related products
- Glimepiride – drug information
- NDC 51655-383 Glimepiride · Glimepiride 2 mg/1 · Northwind Health Company, LLC